|
US20020032160A1
(en)
*
|
1995-02-24 |
2002-03-14 |
Nyce Jonathan W. |
Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
|
|
US5660835A
(en)
*
|
1995-02-24 |
1997-08-26 |
East Carolina University |
Method of treating adenosine depletion
|
|
US6653297B1
(en)
*
|
1997-07-03 |
2003-11-25 |
Medical College Of Hampton Roads |
Control of selective estrogen receptor modulators
|
|
EP0943333A1
(de)
*
|
1998-03-18 |
1999-09-22 |
S.W. Patentverwertungs GmbH |
Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
|
|
GB9923076D0
(en)
|
1999-09-29 |
1999-12-01 |
Phytopharm Plc |
Sapogenin derivatives and their use
|
|
JP2002522462A
(ja)
*
|
1998-08-13 |
2002-07-23 |
ハダシット・メディカル・リサーチ・サービシイズ・アンド・ディベロプメント・カンパニー・リミテッド |
組織外傷に関連した病原プロセスの阻害
|
|
AU7393801A
(en)
*
|
2000-04-12 |
2001-10-23 |
Novartis Ag |
Combination of organic compounds
|
|
JP2004501967A
(ja)
*
|
2000-07-05 |
2004-01-22 |
アストラゼネカ アクチボラグ |
抗アンドロゲン作用およびアロマターゼ阻害を与えるための抗アンドロゲンおよびタモキシフェンの医薬組合せ
|
|
AU2001271162A1
(en)
*
|
2000-07-05 |
2002-01-14 |
Astrazeneca Ab |
Pharmaceutical combination of an anti-androgen and letrozole for providing an anit-androgenic effect and aromatase inhibition
|
|
WO2002002112A1
(en)
*
|
2000-07-05 |
2002-01-10 |
Astrazeneca Ab |
Pharmaceutical combination of an anti-androgen and anastrozole for providing an antiandrogenic effect and aromatase inhibition
|
|
JP2004269356A
(ja)
*
|
2000-12-27 |
2004-09-30 |
Ajinomoto Co Inc |
創傷部癒着防止剤
|
|
US6559177B2
(en)
|
2001-04-19 |
2003-05-06 |
Wyeth |
5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
|
|
US20050070487A1
(en)
*
|
2001-04-24 |
2005-03-31 |
Nyce Jonathan W. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|
|
WO2002085297A2
(en)
*
|
2001-04-24 |
2002-10-31 |
East Carolina University |
Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
|
|
US6589980B2
(en)
|
2001-05-17 |
2003-07-08 |
Wyeth |
Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
|
|
RU2004129577A
(ru)
|
2002-03-04 |
2005-04-10 |
Сосьете Де Консей Де Решерш Э Д`Аппликасьон (Fr) |
Лекарственные композиции с замедленным высвобождением, содержащие пептид-носитель
|
|
AU2003276836B2
(en)
*
|
2002-06-17 |
2007-05-10 |
Epigenesis Pharmaceuticals, Llc. |
Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
|
|
US7405207B2
(en)
|
2002-06-17 |
2008-07-29 |
Epigenesis Pharmaceuticals, Inc. |
Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
|
|
EP2292239A3
(en)
*
|
2003-04-18 |
2011-03-30 |
Advanced Medicine Research Institute |
Remedies for diseases to be applied to eye
|
|
DE602004004698T2
(de)
*
|
2003-07-29 |
2007-11-22 |
Acme S.R.L. |
Verwendung von Stanozolol zur Herstellung von entzündungshemmenden und antidegenerativen Arzneimitteln
|
|
US20050038004A1
(en)
*
|
2003-07-31 |
2005-02-17 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026881A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20110209699A1
(en)
*
|
2003-07-31 |
2011-09-01 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20090285900A1
(en)
*
|
2003-07-31 |
2009-11-19 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20090274676A1
(en)
*
|
2003-07-31 |
2009-11-05 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20090285899A1
(en)
*
|
2003-07-31 |
2009-11-19 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050085430A1
(en)
*
|
2003-07-31 |
2005-04-21 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050101545A1
(en)
*
|
2003-07-31 |
2005-05-12 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026880A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026890A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050113318A1
(en)
*
|
2003-07-31 |
2005-05-26 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20090263381A1
(en)
*
|
2003-07-31 |
2009-10-22 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050043282A1
(en)
*
|
2003-07-31 |
2005-02-24 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026879A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026883A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026884A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026848A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026882A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
|
|
WO2006004795A2
(en)
*
|
2004-06-25 |
2006-01-12 |
The Johns Hopkins University |
Angiogenesis inhibitors
|
|
WO2006034261A2
(en)
*
|
2004-09-21 |
2006-03-30 |
Diapedia, L.L.C. |
Method for design and manufacture of insoles
|
|
US20060189909A1
(en)
*
|
2005-02-24 |
2006-08-24 |
Hurley Timothy B |
Load relieving wound dressing
|
|
US20070009470A1
(en)
*
|
2005-07-06 |
2007-01-11 |
Kin Jung |
Topical/on-the-skin estrogen cream, lotion, ointment, hair tonic, shampoo and wound healing powder
|
|
ITMI20051516A1
(it)
*
|
2005-08-02 |
2007-02-03 |
Prime Europ Therapeuticals |
Derivati 17 alfa-sostituti dell'estradiolo ad attivita' cicatrizzante
|
|
US20070163147A1
(en)
*
|
2005-09-21 |
2007-07-19 |
Cavanagh Peter R |
Method for Design and Manufacture of Insoles
|
|
JP5960944B2
(ja)
|
2006-11-15 |
2016-08-02 |
コーダ セラピューティクス， インコーポレイテッド |
創傷治癒のための改善された方法および組成物
|
|
US20080132475A1
(en)
*
|
2006-12-05 |
2008-06-05 |
Charles Gerald Connor |
Treatment for dry eye
|
|
GB0625962D0
(en)
*
|
2006-12-23 |
2007-02-07 |
Renovo Ltd |
Medicaments and methods for wound healing
|
|
WO2008078074A1
(en)
*
|
2006-12-23 |
2008-07-03 |
Renovo Limited |
Promotion of wound contraction with a compound that promotes oestrogenic activity
|
|
WO2008078073A1
(en)
*
|
2006-12-23 |
2008-07-03 |
Renovo Limited |
Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing
|
|
US20100016264A1
(en)
*
|
2007-12-05 |
2010-01-21 |
Connor Charles G |
Treatment for dry eye using testosterone and progestagen
|
|
GB0724231D0
(en)
*
|
2007-12-12 |
2008-01-30 |
Renono Ltd |
Methods for inhibiting scarring
|
|
EP2234656A2
(en)
*
|
2007-12-21 |
2010-10-06 |
Coda Therapeutics, Inc. |
Improved medical devices
|
|
US20110217313A1
(en)
*
|
2007-12-21 |
2011-09-08 |
Becker David L |
Treatment of orthopedic conditions
|
|
US10279007B2
(en)
|
2010-11-15 |
2019-05-07 |
Oxygenetix Institute, Inc. |
Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
|
|
BR112014005914B1
(pt)
*
|
2011-09-13 |
2021-11-09 |
Brigham Young University |
Produtos para cicatrização de feridas tecidulares
|
|
HRP20211377T1
(hr)
|
2011-11-23 |
2022-01-07 |
Therapeuticsmd, Inc. |
Prirodne kombinirane hormonske supstitucijske formulacije i terapije
|
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
JP6262721B2
(ja)
|
2012-05-11 |
2018-01-17 |
ジェムバックス アンド カエル カンパニー，リミティド |
敗血症の予防用または治療用の組成物
|
|
CN116694597A
(zh)
|
2012-05-11 |
2023-09-05 |
珍白斯凯尔有限公司 |
具有抗炎活性的肽及其在制备抗炎组合物中的应用
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
KR101799904B1
(ko)
|
2012-07-11 |
2017-11-22 |
주식회사 젬백스앤카엘 |
세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물
|
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
|
US10383926B2
(en)
|
2013-06-07 |
2019-08-20 |
Gemvax & Kael Co., Ltd. |
Biological markers useful in cancer immunotherapy
|
|
ES2808076T3
(es)
|
2013-06-21 |
2021-02-25 |
Gemvax & Kael Co Ltd |
Regulador de la secreción hormonal, composición que lo contiene y procedimiento para controlar la secreción hormonal mediante su uso
|
|
EP3072519B1
(en)
|
2013-11-22 |
2020-08-19 |
Gemvax & Kael Co., Ltd. |
Peptide having angiogenesis inhibitory activity and composition containing same
|
|
EP3085380B1
(en)
|
2013-12-17 |
2020-06-17 |
Gemvax & Kael Co., Ltd. |
Composition for treating prostate cancer
|
|
KR102373603B1
(ko)
|
2014-04-11 |
2022-03-14 |
주식회사 젬백스앤카엘 |
섬유증 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물
|
|
EP3138399B1
(en)
|
2014-04-30 |
2023-09-06 |
Gemvax & Kael Co., Ltd. |
Composition for organ, tissue, or cell transplantation, kit, and transplantation method
|
|
KR20170005819A
(ko)
|
2014-05-22 |
2017-01-16 |
쎄러퓨틱스엠디, 인코퍼레이티드 |
천연 복합 호르몬 대체 제형 및 요법
|
|
CN114010788A
(zh)
|
2014-08-22 |
2022-02-08 |
奥克兰联合服务有限公司 |
通道调节剂
|
|
KR102413243B1
(ko)
|
2014-12-23 |
2022-06-27 |
주식회사 젬백스앤카엘 |
안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
|
|
JP6751097B2
(ja)
|
2015-02-27 |
2020-09-02 |
ジェムバックス アンド カエル カンパニー，リミティド |
聴力損傷予防用ペプチド及びそれを含む組成物
|
|
EP3318265B1
(en)
|
2015-07-02 |
2021-08-18 |
Gemvax & Kael Co., Ltd. |
Peptide having anti-viral effect and composition containing same
|
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
|
KR20180126582A
(ko)
|
2016-04-01 |
2018-11-27 |
쎄러퓨틱스엠디, 인코퍼레이티드 |
스테로이드 호르몬 약제학적 조성물
|
|
WO2017176087A1
(ko)
|
2016-04-07 |
2017-10-12 |
주식회사 젬백스앤카엘 |
텔로머라제 활성 증가 및 텔로미어 연장 효능을 가지는 펩티드 및 이를 포함하는 조성물
|
|
WO2020160225A1
(en)
*
|
2019-01-30 |
2020-08-06 |
Ohio State Innovation Foundation |
ESTROGEN RECEPTOR BETA (ERβ) AGONISTS FOR THE TREATMENT OF FIBROTIC CONDITIONS
|
|
KR102842907B1
(ko)
|
2019-09-27 |
2025-08-07 |
(주)아모레퍼시픽 |
신규 진세노사이드를 포함하는 갱년기 증상의 예방 또는 개선용 조성물
|